PROM-话题@MedSci

#PROM#

22篇内容 | 1500人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2020099, encodeId=5751202009969, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=第三届PROMIS国际研讨会精彩回顾, objectType=article, longId=221511, objectId=d0db221511af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0db221511af, replyNumber=0, likeNumber=0, createdTime=2022-11-06, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0db221511af, moduleTitle=第三届PROMIS国际研讨会精彩回顾, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0db221511af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020097, encodeId=e99e202009e79, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=J Headache Pain：依普奈珠单抗预防慢性偏头痛的有效性和安全性：PROMISE-2 III期研究结果, objectType=article, longId=212452, objectId=42a3212452e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42a3212452e6, replyNumber=0, likeNumber=85, createdTime=2022-02-25, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42a3212452e6, moduleTitle=J Headache Pain：依普奈珠单抗预防慢性偏头痛的有效性和安全性：PROMISE-2 III期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42a3212452e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020098, encodeId=bc642020098f7, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=Long non-coding RNA NORAD promotes cell proliferation and glycolysis in non-small cell lung cancer by acting as a sponge for miR-136-5p, objectType=article, longId=221116, objectId=2a872211164b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a872211164b, replyNumber=0, likeNumber=86, createdTime=2022-02-21, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a872211164b, moduleTitle=Long non-coding RNA NORAD promotes cell proliferation and glycolysis in non-small cell lung cancer by acting as a sponge for miR-136-5p, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a872211164b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020096, encodeId=9bca202009664, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=罗氏同意以14亿美元收购Promedior，获得肺纤维化和骨髓纤维化II期候选药物, objectType=article, longId=183197, objectId=fe4e18319eb6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe4e18319eb6, replyNumber=0, likeNumber=86, createdTime=2020-07-08, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe4e18319eb6, moduleTitle=罗氏同意以14亿美元收购Promedior，获得肺纤维化和骨髓纤维化II期候选药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe4e18319eb6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020091, encodeId=4d4c20200917d, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=EASL大会：Promethera干细胞疗法HepaStem在2a临床显示出对急性肝衰竭治疗的安全有效性, objectType=article, longId=164365, objectId=dbfc16436511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbfc16436511, replyNumber=0, likeNumber=75, createdTime=2019-06-04, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbfc16436511, moduleTitle=EASL大会：Promethera干细胞疗法HepaStem在2a临床显示出对急性肝衰竭治疗的安全有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbfc16436511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020094, encodeId=a2862020094b7, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=J Clin Oncol：患者报道结果测量信息系统（PROMIS）的性兴趣和满意度测量有效性研究, objectType=article, longId=179076, objectId=80481e90765c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80481e90765c, replyNumber=0, likeNumber=80, createdTime=2020-07-16, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80481e90765c, moduleTitle=J Clin Oncol：患者报道结果测量信息系统（PROMIS）的性兴趣和满意度测量有效性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80481e90765c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020095, encodeId=060220200959f, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=MSD与Promega合作开发Keytruda伴侣诊断，以判断哪些患者会受益于PD-1抑制剂的治疗, objectType=article, longId=182746, objectId=ca52182e4662, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca52182e4662, replyNumber=0, likeNumber=81, createdTime=2020-10-19, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca52182e4662, moduleTitle=MSD与Promega合作开发Keytruda伴侣诊断，以判断哪些患者会受益于PD-1抑制剂的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca52182e4662)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020092, encodeId=02f9202009241, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=Promethera宣布在2a期临床研究中首次给药，评估世界首例肝干细胞疗法治疗晚期NASH患者, objectType=article, longId=165934, objectId=f5dd165934c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5dd165934c0, replyNumber=0, likeNumber=89, createdTime=2019-09-01, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5dd165934c0, moduleTitle=Promethera宣布在2a期临床研究中首次给药，评估世界首例肝干细胞疗法治疗晚期NASH患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5dd165934c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020090, encodeId=447e202009008, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=MYR Pharma的NTCP受体抑制剂Bulevirtide治疗慢性丁型肝炎感染被授予Promising Innovative Medicine 称号, objectType=article, longId=161805, objectId=b36616180596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b36616180596, replyNumber=0, likeNumber=80, createdTime=2019-08-24, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b36616180596, moduleTitle=MYR Pharma的NTCP受体抑制剂Bulevirtide治疗慢性丁型肝炎感染被授予Promising Innovative Medicine 称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b36616180596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020093, encodeId=cfc0202009366, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=药物警戒：诺华公司在美国范围内自愿召回Promacta 12.5 mg口服悬浮剂, objectType=article, longId=165993, objectId=91ee16599363, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91ee16599363, replyNumber=0, likeNumber=96, createdTime=2020-02-09, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91ee16599363, moduleTitle=药物警戒：诺华公司在美国范围内自愿召回Promacta 12.5 mg口服悬浮剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91ee16599363)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020089, encodeId=c05220200892d, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=Arthritis Care Res：RA患者启动或换用DMARD治疗的患者报告结局检测信息系统（PROMIS）反应性, objectType=article, longId=144163, objectId=ce5514416383, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce5514416383, replyNumber=0, likeNumber=80, createdTime=2018-11-08, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce5514416383, moduleTitle=Arthritis Care Res：RA患者启动或换用DMARD治疗的患者报告结局检测信息系统（PROMIS）反应性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce5514416383)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020085, encodeId=5466202008504, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=Ann Lab Med：韩国第一例由PROM1突变导致STGD4被发现！, objectType=article, longId=111303, objectId=b24d11130364, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b24d11130364, replyNumber=0, likeNumber=0, createdTime=2018-03-29, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b24d11130364, moduleTitle=Ann Lab Med：韩国第一例由PROM1突变导致STGD4被发现！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b24d11130364)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020088, encodeId=b64820200888d, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=Lancet Oncol：PROMISE评分能为恶性胸腔积液的预后提供很好预测价值, objectType=article, longId=144141, objectId=8865144141c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8865144141c3, replyNumber=0, likeNumber=63, createdTime=2018-11-06, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8865144141c3, moduleTitle=Lancet Oncol：PROMISE评分能为恶性胸腔积液的预后提供很好预测价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8865144141c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020087, encodeId=8cf6202008e2e, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=Diabetologia：前瞻性代谢和胰岛细胞评估（PROMISE）队列中NEFA组成与胰岛素敏感性和β细胞功能的关联, objectType=article, longId=137241, objectId=f40e13e24154, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f40e13e24154, replyNumber=0, likeNumber=74, createdTime=2019-03-13, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f40e13e24154, moduleTitle=Diabetologia：前瞻性代谢和胰岛细胞评估（PROMISE）队列中NEFA组成与胰岛素敏感性和β细胞功能的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f40e13e24154)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020086, encodeId=9005202008629, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=苏格兰的Synpromics扩大与UCL在基因治疗方面的合作, objectType=article, longId=127951, objectId=99f912e9518b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99f912e9518b, replyNumber=0, likeNumber=0, createdTime=2018-02-20, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99f912e9518b, moduleTitle=苏格兰的Synpromics扩大与UCL在基因治疗方面的合作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99f912e9518b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020084, encodeId=f21b202008432, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=Neurology：缺血性卒中生理功能的检测：PROMIS 优于SIS-16量表, objectType=article, longId=72448, objectId=1163e24486b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1163e24486b, replyNumber=0, likeNumber=81, createdTime=2017-04-24, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1163e24486b, moduleTitle=Neurology：缺血性卒中生理功能的检测：PROMIS 优于SIS-16量表, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1163e24486b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020080, encodeId=02fb202008088, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=AJOG：炎症因子预测早产胎膜早破（PPROM）胎儿神经系统情况, objectType=article, longId=47308, objectId=2c9e4e3083b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c9e4e3083b, replyNumber=0, likeNumber=76, createdTime=2016-01-30, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c9e4e3083b, moduleTitle=AJOG：炎症因子预测早产胎膜早破（PPROM）胎儿神经系统情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c9e4e3083b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020083, encodeId=e9442020083f9, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=ESC 2015：起搏治疗未能改善大面积心梗患者预后（PRomPT试验）, objectType=article, longId=55674, objectId=5a76556e47c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a76556e47c, replyNumber=0, likeNumber=68, createdTime=2015-10-09, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a76556e47c, moduleTitle=ESC 2015：起搏治疗未能改善大面积心梗患者预后（PRomPT试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a76556e47c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020082, encodeId=7600202008248, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=NEJM：可疑冠状动脉疾病的非侵入性检查比较（PROMISE试验）, objectType=article, longId=48227, objectId=99d34822e0f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99d34822e0f, replyNumber=0, likeNumber=0, createdTime=2015-05-03, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99d34822e0f, moduleTitle=NEJM：可疑冠状动脉疾病的非侵入性检查比较（PROMISE试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99d34822e0f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2020081, encodeId=955720200818e, content=<a href='/topic/show?id=9a7f14e277b' target=_blank style='color:#2F92EE;'>#PROM#</a>, objectTitle=AJOG：TVCL+AFI对PPROM的分娩预测, objectType=article, longId=47891, objectId=41a04e891ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41a04e891ce, replyNumber=0, likeNumber=69, createdTime=2016-02-03, rootId=0, userName=12498a1cm67暂无昵称, userId=1fa82500120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41a04e891ce, moduleTitle=AJOG：TVCL+AFI对PPROM的分娩预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41a04e891ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

PROM

2020-05-29

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

第三届PROMIS国际研讨会精彩回顾

2022-11-06

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

J Headache Pain：依普奈珠单抗预防慢性偏头痛的有效性和安全性：PROMISE-2 III期研究结果

2022-02-25

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

Long non-coding RNA NORAD promotes cell proliferation and glycolysis in non-small cell lung cancer by acting as a sponge for miR-136-5p

2022-02-21

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

罗氏同意以14亿美元收购Promedior，获得肺纤维化和骨髓纤维化II期候选药物

2020-07-08

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

EASL大会：Promethera干细胞疗法HepaStem在2a临床显示出对急性肝衰竭治疗的安全有效性

2019-06-04

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

J Clin Oncol：患者报道结果测量信息系统（PROMIS）的性兴趣和满意度测量有效性研究

2020-07-16

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

MSD与Promega合作开发Keytruda伴侣诊断，以判断哪些患者会受益于PD-1抑制剂的治疗

2020-10-19

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

Promethera宣布在2a期临床研究中首次给药，评估世界首例肝干细胞疗法治疗晚期NASH患者

2019-09-01

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

MYR Pharma的NTCP受体抑制剂Bulevirtide治疗慢性丁型肝炎感染被授予Promising Innovative Medicine 称号

2019-08-24

hb2008ye (审核中...)

前往app查看评论内容

#PROM#

药物警戒：诺华公司在美国范围内自愿召回Promacta 12.5 mg口服悬浮剂

2020-02-09

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

Arthritis Care Res：RA患者启动或换用DMARD治疗的患者报告结局检测信息系统（PROMIS）反应性

2018-11-08

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

Ann Lab Med：韩国第一例由PROM1突变导致STGD4被发现！

2018-03-29

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

Lancet Oncol：PROMISE评分能为恶性胸腔积液的预后提供很好预测价值

2018-11-06

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

Diabetologia：前瞻性代谢和胰岛细胞评估（PROMISE）队列中NEFA组成与胰岛素敏感性和β细胞功能的关联

2019-03-13

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

苏格兰的Synpromics扩大与UCL在基因治疗方面的合作

2018-02-20

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

Neurology：缺血性卒中生理功能的检测：PROMIS 优于SIS-16量表

2017-04-24

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

AJOG：炎症因子预测早产胎膜早破（PPROM）胎儿神经系统情况

2016-01-30

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

ESC 2015：起搏治疗未能改善大面积心梗患者预后（PRomPT试验）

2015-10-09

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

NEJM：可疑冠状动脉疾病的非侵入性检查比较（PROMISE试验）

2015-05-03

12498a1cm67暂无昵称 (审核中...)

前往app查看评论内容

#PROM#

AJOG：TVCL+AFI对PPROM的分娩预测

2016-02-03

科室
- - 订阅+
  - 更多科室
工具
服务